Industrial Machinery company 3M India announced Q2FY26 results Operating Income: Rs 1,266 crore compared to Rs 1,111 crore during Q2FY25, change 14.0%. EBITDA: Rs 268 crore compared to Rs 201 crore during Q2FY25, change 33.1%. PBT: Rs 251 crore compared to Rs 182 crore during Q2FY25, change 37.0%. PAT: Rs 191 crore compared to Rs 134 crore during Q2FY25, change 43.0%. Ramesh Ramadurai, Managing Director, 3M India, said: “The Company delivered 14.0% sales growth in Q2FY26 versus Q2FY25. The Company delivered broad-based growth across all four business segments. For the quarter, Healthcare sales grew 14.9%, Consumer 14.6%, Transportation & Electronics 12.9% and Safety & Industrial 12.3% versus prior year. We are encouraged with the sales growth in Q2FY26 as well as H1FY26, despite timing benefit in the quarter due to certain project-related businesses. The Company’s profit after tax grew 43.0% to Rs. 191 crores in Q2FY26. The Company maintained higher spend levels during the quarter in sales and marketing to improve market penetration. I thank our teams for their focus on customers and disciplined execution during the quarter." Result PDF
Industrial Machinery company 3M India announced Q1FY26 results Operating Income: Rs 1,196 crore compared to Rs 1,047 crore during Q1FY25, change 14.3%. EBITDA: Rs 257 crore compared to Rs 227 crore during Q1FY25, change 13.0%. PBT: Rs 239 crore compared to Rs 211 crore during Q1FY25, change 13.5%. PAT: Rs 178 crore compared to Rs 157 crore during Q1FY25, change 13.1%. Ramesh Ramadurai, Managing Director of 3M India, said: “The Company delivered 14.3% sales growth in Q1FY26 versus Q1FY25. The Company delivered broad-based growth across all four business segments. For the quarter, Healthcare and Consumer segments grew by 20% each, Safety & Industrial grew by 11.9% and Transportation & Electronics grew by 11.2% versus prior year. We are encouraged with the sales growth in Q1FY26, even after allowing for a softer comparison with Q1FY25. These results also reflect early traction from the sales and marketing investments the Company made since the middle of the previous financial year to improve our market penetration and commercial excellence. The Company’s profit after tax grew 13.1% to Rs 178 crore. The increase in expenses were mitigated by efficiencies in material cost. I thank our teams for their disciplined execution during the quarter, and for maintaining a strong customer focus." Result PDF
Industrial Machinery company 3M India announced Q4FY25 & FY25 results Q4FY25 Financial Highlights: Sales & Other Operating Income: Rs 1,198 crore in January-March 2025, showing a 9% growth compared to Rs 1,095 crore in January-March 2024. Other Income: Rs 14 crore in January-March 2025, indicating a -53% decrease compared to Rs 30 crore in January-March 2024. EBITDA: Rs 240 crore in January-March 2025, reflecting a -2% decrease compared to Rs 245 crore in January-March 2024. PBT: Rs 225 crore in January-March 2025, showing a -3% decrease compared to Rs 231 crore in January-March 2024. PAT: Rs 71 crore in January-March 2025, indicating a -60% decrease compared to Rs 173 crore in January-March 2024. FY25 Financial Highlights: Sales & Other Operating Income: Rs 4,446 crore in April-March 2025, showing a 6% growth compared to Rs 4,189 crore in April-March 2024. Other Income: Rs 70 crore in April-March 2025, indicating a -10% decrease compared to Rs 78 crore in April-March 2024. EBITDA: Rs 840 crore in April-March 2025, reflecting a 0% growth compared to Rs 837 crore in April-March 2024. PBT: Rs 773 crore in April-March 2025, showing a -1% decrease compared to Rs 781 crore in April-March 2024. PAT: Rs 476 crore in April-March 2025, indicating a -18% decrease compared to Rs 583 crore in April-March 2024. Commenting on the fourth quarter and financial year ended March 31, 2025, results Ramesh Ramadurai, Managing Director of 3M India, said “the Company delivered 9.5% sales growth in the fourth quarter and 6.1% sales growth for the full year, both versus prior period. For the quarter, Transportation & Electronics grew 2.1%, Healthcare grew 13.5%, Safety & Industrial -14.4%, Consumer 14.9% versus prior year. For the Financial Year 2024-25, Healthcare business led the Company’s growth, followed by Consumer business. Our teams continued to execute well, with focus on customers and supply partners. I would like to thank our employees for their dedication and customer focus, and to all our stakeholders for their support to our Company.” Result PDF